AccuStem Sciences, Inc.
ACUT
$0.16
-$0.07-28.89%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 37.07% | -10.33% | -38.24% | -21.85% | -44.28% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -100.00% | -88.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.53% | -84.35% | -90.61% | 26.06% | 66.91% |
| Change in Net Operating Assets | -100.90% | 82.77% | 330.81% | -351.82% | 637.27% |
| Cash from Operations | -1,252.31% | -28.95% | 5,500.00% | -177.24% | 110.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 13.83% | -- | 162.25% | -100.00% |
| Total Debt Repaid | 4.51% | 11.76% | 29.63% | 3.39% | -22.58% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,038.35% | 15.86% | 29.63% | 180.96% | -110.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.00% | -105.43% | 98.44% | -88.89% | -113.62% |